Viruses Like Chickenpox And Shingles Provide Difficulties For Public Health

Authors

  • Maryam Jamil
  • Darlington David Faijue
  • Robina Iqbal

DOI:

https://doi.org/10.63682/jns.v14i25S.9767

Keywords:

Herpes zoster, chickenpox, population epidemiology, and Mexico

Abstract

This study aims to assess the epidemiological behaviour of varicella and herpes zoster (HZ) to identify whether or not health policies are required to reduce the prevalence of these diseases and stop complications from occurring. Both the materials and the processes. We analysed data from the National Information System for Epidemiological Surveillance (SUIVE) from 2000 to 2013 to determine the frequency of the occurrences. To evaluate the discharge data of varicella and HZ, we reviewed information from the National System of Health information called Sinais. This is the outcome. A total of 296,733 instances of chickenpox were reported annually, with 57% of those cases occurring in children younger than nine years old and the majority occurring during March and May. The number of patients discharged from hospitals with varicella between 2004 and 2012 was 17,398. Of those patients, 4.6% had meningoectolitis, 2.5% had pneumonia, and 18% had various sequelae. Regarding herpes zoster, there were 7 042 discharges, the majority of patients afflicted were those who were 65 years old or older, and the ratio of females to males was 1.3:1. Neuralgia (17%), eye involvement (7%), meningoencephalitis (5.4%), disseminated disease (2.8%). Other problems (5.4%) were the most common consequences, and the time spent in the hospital ranged from 6.4 to 13.3 days. The final thoughts. These findings are in line with the research that has been conducted in other nations. A discussion is held regarding vaccination's significance in preventing infection in children and adults

Downloads

Download data is not yet available.

References

1. Coughlin, S. S. (2012). Anxiety and depression: linkages with viral diseases. Public Health Reviews, 34, 1-17.

2. Curran, D., Patterson, B. J., Carrico, J., Salem, A., La, E. M., Lorenc, S., Hicks, K. A., Poston, S., & Carpenter, C. F. (2023). Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human Vaccines & Immunotherapeutics, 19(1), 2167907.

3. Fairley, C. K., & Miller, E. (1996). Is varicella-zoster virus epidemiology a changing scene? Journal of Infectious Diseases, 174(Supplement_3), S314-S319.

4. Gabutti, G., Valente, N., Kuhdari, P., Lupi, S., & Stefanati, A. (2016). Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine. Journal of Medical Microbiology, 65(12), 1363-1369.

5. Giubilini, A. (2020). Using individuals as (mere) means managing infectious diseases without vaccines. Should we purposely infect young people with coronavirus? The American Journal of Bioethics, 20(9), 62-65.

6. Gnann Jr, J. W. (2002). Varicella-zoster virus: atypical presentations and unusual complications. The Journal of Infectious Diseases, 186(Supplement_1), S91-S98.

7. Hu, G., Du, H., Liu, Y., Wu, G., & Han, J. (2022). Herpes B virus: History, zoonotic potential, and public health implications. Biosafety and Health, 4(04), 213-219.

8. Kennedy, P. G., Mogensen, T. H., & Cohrs, R. J. (2021). Recent issues in varicella-zoster virus latency. Viruses, 13(10), 2018.

9. Lin, F., & Hadler, J. L. (2000). Epidemiology of primary varicella and herpes zoster hospitalisations: the pre-varicella vaccine era. Journal of Infectious Diseases, 181(6), 1897-1905.

10. Malm, H., & Navin, M. C. (2020). Pox parties for grannies? Chickenpox, exogenous boosting, and harmful injustices. The American Journal of Bioethics, 20(9), 45-57.

11. McElhaney, J. E., Verschoor, C., & Pawelec, G. (2019). Zoster vaccination in older adults: efficacy and public health implications. The Journals of Gerontology: Series A, 74(8), 1239-1243.

12. Newman, A. M., & Jhaveri, R. (2019). Myths and misconceptions: varicella-zoster virus exposure, infection risks, complications, and treatments. Clinical therapeutics, 41(9), 1816-1822.

13. Rajan, P., & Rivers, J. K. (2001). Varicella zoster virus. Recent advances in management. Canadian Family Physician, 47(11), 2299-2304.

14. Steiner, I., Kennedy, P. G., & Pachner, A. R. (2007). The neurotropic herpes viruses: herpes simplex and varicella-zoster. The Lancet Neurology, 6(11), 1015-1028.

15. Swali, R., Wiggins, C., Farooq, S., Shah, R. A., & Limmer, E. (2021). Reemerging Viral Infections: Implications of Lack of Vaccination. In Overcoming Antimicrobial Resistance of the Skin (pp. 111-129). Springer

Downloads

Published

2025-05-15

How to Cite

1.
Jamil M, David Faijue D, Iqbal R. Viruses Like Chickenpox And Shingles Provide Difficulties For Public Health. J Neonatal Surg [Internet]. 2025 May 15 [cited 2026 May 25];14(25S):1083-9. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9767